GlassScriptPhysician profile
Jennifer L Bevins
NPI 1972595841
$5,481.85
in general payments reported to CMS, 2019-2025
39 companies · $879 in 2025
The $879 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,863 · 2020: $313 · 2021: $283 · 2022: $652 · 2023: $779 · 2024: $712 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.00 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,101.74 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $676.06 | 2019-2024 | Lynparza |
| Baxter Healthcare | $350.78 | 2024-2025 | Perclot, Adept, Seprafilm |
| Astellas Pharma US INC | $328.35 | 2023-2025 | Veozah |
| Tesaro, INC. | $249.87 | 2019 | |
| Exeltis, USA INC. | $229.85 | 2022-2025 | Slynd |
| Merck Sharp & Dohme LLC | $224.55 | 2019-2025 | Gardasil 9, Gardasil |
| Pfizer INC. | $211.64 | 2019-2024 | |
| Abbvie INC. | $205.43 | 2022-2024 | Liletta |
| Mayne Pharma Commercial LLC | $165.42 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $157.53 | 2023-2025 | Myfembree |
| Clovis Oncology, INC. | $145.41 | 2020-2021 | |
| Therapeuticsmd, INC. | $141.98 | 2019-2022 | |
| Glaxosmithkline, LLC. | $128.82 | 2022-2023 | Zejula |
| Exact Sciences Corporation | $128.18 | 2023-2024 | Cologuard Collection Kit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $114.64 | 2022-2025 | Nexplanon, Jada System |
| Immunogen, INC. | $110.70 | 2023 | Elahere |
| Lupin INC. | $92.36 | 2019-2020 | |
| Medtronic, INC. | $87.78 | 2022 | |
| Novo Nordisk INC | $74.37 | 2024-2025 | Wegovy |
| Hologic Sales and Service, LLC | $61.26 | 2019-2025 | Omni Hysteroscope |
| Amag Pharmaceuticals, INC. | $57.31 | 2019-2020 | |
| Myovant Sciences INC. | $50.58 | 2022 | |
| Coopersurgical, INC. | $47.66 | 2022-2024 | Wallach Cryosurgical Equipment |
| Bayer Healthcare Pharmaceuticals INC. | $36.77 | 2024 | |
| Millicent US INC | $35.55 | 2024-2025 | Femlyv |
| Evofem Biosciences, INC. | $32.97 | 2022 | |
| Biogen, INC. | $29.09 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $29.07 | 2022 | |
| Covidien LP | $26.89 | 2019 | |
| Allergan, INC. | $25.88 | 2019 | |
| Agile Therapeutics, INC. | $25.33 | 2022-2023 | Twirla |
| Ge Healthcare | $25.16 | 2025 | |
| Ethicon US, LLC | $23.31 | 2025 | Dermabond |
| Duchesnay USA Incorporated | $15.01 | 2019 | |
| Shield Therapeutics INC | $13.76 | 2023 | Accrufer |
| Meditrina | $13.18 | 2025 | |
| Alydia Health | $7.61 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.